DLBCL 1L—What to Expect beyond R-CHOP? View External Link Categories Peer Reviewed Publications Reviews Topics: 1L therapy; bispecific antibodies CAR-T-cells diffuse large B-cell lymphoma DLBCL COO immuno-oncology agents targeted therapeutics